title: High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
abstract: OBJECTIVE
  To study degree of blood pressure (BP) control in primary healthcare (PHC) treated hypertensive patients in relation to sex, age, drug treatment, and concomitant diseases.
  
  
  METHODS
  Random sample of patients with hypertension.
  
  
  METHODS
  Ten PHC centres in the Region of Skåne, Sweden.
  
  
  METHODS
  All the 30- to 95-year-old patients with hypertension who during the period 12 September to 24 September 2004 attended their PHC (146 men and 229 women).
  
  
  METHODS
  Achievement of BP control (< 140/90 mmHg) according to European guidelines.
  
  
  RESULTS
  Some 90% had been treated > 12 months, 40% had mono-therapy, 15% > or = 3 drugs. Use of diuretics was more common in women while use of ACE inhibitors and calcium channel blockers was common in men. Inadequate BP control was related to age; only 22% had BP < 140/90 mmHg, 38% had a BP > or = 160/100 mmHg. BP decline was inversely related to BP measured 12 months or more prior to the present follow-up (r = - 0.64, p < 0.001, for systolic and r = - 0.67, p < 0.001, for diastolic BP). The systolic or diastolic BP had in every fifth patient during treatment increased by > or = 10 mmHg. No association was found between average BP decline and prescribed number of drugs.
  
  
  CONCLUSIONS
  A minority of the patients had BP below the level (< 140/90 mmHg) recommended by European guidelines. This study illustrates the need for continued follow-up of defined groups of patients in order to improve quality of care.
authors.affiliation: Department of Clinical Sciences in Malmö, Epidemiological Research Group, Sweden. Bo.Hedblad@med.lu.se
authors.forename: Bo
authors.initials: B
authors.lastname: Hedblad
authors.forename: Christina
authors.initials: C
authors.lastname: Nerbrand
authors.forename: Richard
authors.initials: R
authors.lastname: Ekesbo
authors.forename: Lennart
authors.initials: L
authors.lastname: Johansson
authors.forename: Patrik
authors.initials: P
authors.lastname: Midlöv
authors.forename: Inger
authors.initials: I
authors.lastname: Brunkstedt
authors.forename: Per
authors.initials: P
authors.lastname: Svensson
authors.forename: Staffan
authors.initials: S
authors.lastname: Gyllerup
authors.forename: Birgitta
authors.initials: B
authors.lastname: Sträng
authors.forename: Robert
authors.initials: R
authors.lastname: Persson
authors.forename: Lars
authors.initials: L
authors.lastname: Janzon
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001795:Blood Pressure Determination; D003151:Community Health Centers / Q000592:standards; D003430:Cross-Sectional Studies; D005194:Family Practice / Q000592:standards; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents